Clinical Trials
19
Active:0
Completed:19
Trial Phases
3 Phases
Phase 1:10
Phase 2:1
Phase 3:8
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (52.6%)Phase 3
8 (42.1%)Phase 2
1 (5.3%)A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State
Phase 1
Completed
- Conditions
- Healthy SubjectsBioavailabilityPharmacokinetics
- Interventions
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01121926
Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01121913
A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT01121900
A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Zaldiar®Drug: Ultracet®, multiple doses, (fed & fasting)
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2012-04-25
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT00973232
- Locations
- 🇬🇧
Guy's Drug Research Unit, Quintiles Ltd, London, United Kingdom
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT00952068
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found